https://www.selleckchem.com/pr....oducts/pci-34051.htm
1 to 12.7 T-score points. We recommend to use the predictive modeling method, possibly supplemented with the vignette-based method, in future MIC studies. We consider a MIC value of 2-6 T-score points for PROMIS measures reasonable to assume at this point. For surgical interventions a higher MIC value might be appropriate. We recommend more high-quality studies estimating MIC values for PROMIS. Tocilizumab randomized clinical trial results are heterogeneous because of the heterogenous population included in them. We conducted a meta-a